These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6295940)

  • 21. Protective effect of biological response modifiers on murine cytomegalovirus infection.
    Ebihara K; Minamishima Y
    J Virol; 1984 Jul; 51(1):117-22. PubMed ID: 6202880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of NK cell activity in age-dependent resistance of mice to murine cytomegalovirus infection.
    Hayashi K; Eizuru Y; Sato S; Minamishima Y
    Microbiol Immunol; 1985; 29(10):939-50. PubMed ID: 3001484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a retroviral immunodeficiency syndrome on resistance to MCMV: a role for natural killer cells.
    Peacock CD; Price P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):120-8. PubMed ID: 7552475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer of anti-cytomegalovirus effect of interleukin-2-activated bone marrow: potential application in transplantation.
    Agah R; Charak BS; Chen V; Mazumder A
    Blood; 1991 Aug; 78(3):720-7. PubMed ID: 1650263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens.
    Selgrade MK; Ahmed A; Sell KW; Gershwin ME; Steinberg AD
    J Immunol; 1976 May; 116(5):1459-65. PubMed ID: 178797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymic humoral factor, THF-gamma 2, enhances immunotherapy of murine cytomegalovirus (MCMV) infection by both CD4+ and CD8+ immune T cells.
    Rager-Zisman B; Segev Y; Blagerman S; Palmon A; Tel-Or S; Pecht M; Trainin N; Burstein Y
    Immunol Lett; 1993 Dec; 39(1):23-31. PubMed ID: 7908278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperexpansion of Functional Viral-Specific CD8+ T Cells in Lymphopenia-Associated MCMV Pneumonitis.
    Shah PD; Zhong Q; Lendermon EA; Pipeling MR; McDyer JF
    Viral Immunol; 2015 Jun; 28(5):255-64. PubMed ID: 26046830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice.
    Almishaal AA; Mathur PD; Hillas E; Chen L; Zhang A; Yang J; Wang Y; Yokoyama WM; Firpo MA; Park AH
    PLoS Pathog; 2017 Aug; 13(8):e1006599. PubMed ID: 28859161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host-mediated antiviral activity of Lactobacillus casei against cytomegalovirus infection in mice.
    Ohashi T; Yoshida A; Minamishima Y
    Biotherapy; 1988; 1(1):27-39. PubMed ID: 2484431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
    Bale JF; O'Neil ME; Folberg R
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse cytomegalovirus is infectious for rats and alters lymphocyte subsets and spleen cell proliferation.
    Smith CB; Wei LS; Griffiths M
    Arch Virol; 1986; 90(3-4):313-23. PubMed ID: 3015085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.
    Bukowski JF; Warner JF; Dennert G; Welsh RM
    J Exp Med; 1985 Jan; 161(1):40-52. PubMed ID: 2981954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells.
    Salem ML; Hossain MS
    Int J Immunopharmacol; 2000 Sep; 22(9):707-18. PubMed ID: 10884591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific suppression of delayed type hypersensitivity to murine cytomegalovirus in MCMV-infected mice.
    Chong KT; Mims CA
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2433-9. PubMed ID: 6315864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between natural killer cell activation in the bone marrow and haemopoietic dysfunction following cytomegalovirus infection of mice.
    Gibbons AE; Shellam GR; Price P
    Immunology; 1997 Jun; 91(2):227-33. PubMed ID: 9227321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo administration of monoclonal antibody to the NK 1.1 antigen of natural killer cells: effect on acute murine cytomegalovirus infection.
    Shanley JD
    J Med Virol; 1990 Jan; 30(1):58-60. PubMed ID: 2154543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Modifiers of Natural Killer Cells, Immune Responsiveness and Lymphoid Tissue Remodeling Together Increase Host Resistance to Viral Infection.
    Gillespie AL; Teoh J; Lee H; Prince J; Stadnisky MD; Anderson M; Nash W; Rival C; Wei H; Gamache A; Farber CR; Tung K; Brown MG
    PLoS Pathog; 2016 Feb; 12(2):e1005419. PubMed ID: 26845690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV).
    Katorza E; Pecht M; Apte RN; Benharroch D; Burstein Y; Trainin N; Rager-Zisman B
    Clin Exp Immunol; 1987 Nov; 70(2):268-75. PubMed ID: 2448072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons.
    Kosugi I; Kawasaki H; Arai Y; Tsutsui Y
    Am J Pathol; 2002 Sep; 161(3):919-28. PubMed ID: 12213720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.